Elanco Animal Health Inc — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$1.14B↑+12.2%
2025-09-30$1.14B↑+10.4%$-34M↓-109.3%
2025-06-30$1.24B↑+4.8%$11M↑+122.0%
2025-03-31$1.19B↓-1.0%$67M↑+109.4%
2024-12-31$1.02B↓-1.4%
2024-09-30$1.03B↓-3.6%$364M↑+133.2%
2024-06-30$1.18B↑+12.0%$-50M↑+48.5%
2024-03-31$1.21B↓-4.1%$32M↓-68.9%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$1.14B
↑+12.2% +$124M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 36 quarters

margin trajectory tells the operating-leverage story
Gross Margin↑+0.6pts
51.5%
Operating Margin
Net Margin↓-38.3pts
-3.0%

Go deeper